An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...
1h
Madison WMTV on MSN‘She is my kidney champion:’ Madison family seeking living kidney donorMira’s father, Dobrin, has been diagnosed with Stage 5 Chronic Kidney Disease and now requires dialysis. Now, Mira is working ...
His brother, Matthew, was battling stage 5 kidney disease, and time was running out. When he learned the wait for a donor ...
The owner of Lotte posted a heartfelt plea on social media on Tuesday, and it’s already yielding some leads, he said.
Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.
Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal function ...
2d
News Medical on MSNInnovative method improves understanding of cellular and molecular mechanisms in kidney diseasesResearchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...
Novo Nordisk’s OZEMPIC Approval Heat Up the Chronic Kidney Disease Therapeutic Market | DelveInsight
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Bohl went through a yearlong screening process only to find out he wasn’t a match for Matthew. However, he learned about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results